Stockreport

Aptinyx to Present Preclinical Data on NMDA Receptor Modulator NYX-2925 at the American College of Neuropsychopharmacology’s Annual Meeting

Aptinyx Inc.  (APTX) 
Last aptinyx inc. earnings: 3/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aptinyx.com/investors-media
PDF EVANSTON, Ill., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the t [Read more]